GENSIGHT BIOLOGICS SA revenue breakdown overview

GENSIGHT BIOLOGICS SA revenue for the last year amounted to 3.00 M EUR, the most of which — 1.27 M EUR — came from its highest performing source at the moment, Novel Therapies for Mitochondrial and Neurodegenerative Disease, the year earlier bringing 2.58 M EUR. The greatest contribution to the revenue figure was made by France — last year it brought GENSIGHT BIOLOGICS SA 1.27 M EUR, and the year before that — 2.58 M EUR.